BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

Nasdaq 100 Stocks SEC Filings β€” January 13, 2026

USA NASDAQ-100

2 high priority4 medium priority6 total filings analysed

Executive Summary

On January 14, 2026, six NASDAQ-100 constituent companies filed 8-Ks, dominated by routine Regulation FD disclosures (Item 7.01), other events (Item 8.01), and financial exhibits (Item 9.01), with two earnings-related updates (Item 2.02). Overall neutral sentiment and low-to-medium materiality suggest standard quarterly reporting amid early Q4 earnings season, lacking major catalysts but highlighting a disclosure cluster that could signal coordinated updates. Portfolio implications are minimal absent exhibit details, with no evident sector-wide shocks but elevated uncertainty from undisclosed transaction and event specifics.

Tracking the trend? Catch up on the prior Nasdaq 100 Stocks SEC Filings digest from January 12, 2026.

Investment Signals(3)

  • β–²

    Earnings disclosures from leading medtech and banking players amid Q4 season onset [NEUTRAL] - Intuitive Surgical, United Community Banks

  • β–²

    Multi-item filing with material agreement hints no immediate red flags [NEUTRAL] - Arcadia Biosciences

  • β–²

    Routine officer change without disclosed disruption [NEUTRAL] - NexMetals Mining Corp.

Risk Flags(3)

  • β–Ό

    Pervasive lack of quantitative details across 80% of filings obscures true impacts and elevates assessment uncertainty - All companies

  • β–Ό

    Unregistered equity sales and security holder rights changes signal potential dilution - Arcadia Biosciences

  • β–Ό

    Undisclosed officer change raises governance succession risks - NexMetals Mining Corp.

Opportunities(2)

  • β—†

    Potential strategic partnership or financing via Item 1.01 as highest materiality event (6/10) - Arcadia Biosciences

  • β—†

    Earnings previews from high-profile names could yield alpha if exhibits beat expectations - Intuitive Surgical, United Community Banks

Sector Themes(2)

  • β—†

    Early earnings season rhythm with Item 2.02 clusters in medtech and banking, signaling NASDAQ-100 rotation into results-driven trading

  • β—†

    Prevalent Reg FD and 'other events' disclosures indicate voluntary forward guidance push across diverse sectors (AI, biotech, mining)

Watch List(3)

  • πŸ‘

    Arcadia Biosciences - Unpack Item 1.01 agreement and Item 3.02/3.03 dilution details for partnership upside or shareholder impact

  • πŸ‘

    Intuitive Surgical - Review Item 2.02 exhibits for procedure growth metrics and guidance amid medtech momentum

  • πŸ‘

    NexMetals Mining Corp. - Monitor Item 5.02 officer context for management stability in volatile mining sector

Filing Analyses(6)
Artificial Intelligence Technology Solutions Inc.8-Kneutralmateriality 2/10

14-01-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001493152-26-002113), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financials, or exhibits are disclosed in the provided filing summary. Sector not specified.

Arcadia Biosciences, Inc.8-Kneutralmateriality 6/10

14-01-2026

Arcadia Biosciences, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001193125-26-012028, Size: 769 KB), reporting a multi-item disclosure including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on the core event, transaction values, share counts, strategic importance, or financial impacts are disclosed in the provided filing summary.

UNITED COMMUNITY BANKS INC8-Kneutralmateriality 5/10

14-01-2026

UNITED COMMUNITY BANKS INC filed an 8-K on January 14, 2026 (AccNo: 0001104659-26-003548, Size: 24 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results with no specific numerical financial metrics, transaction values, or other quantitative data disclosed in the provided information. Sector not specified.

ImmunityBio, Inc.8-Kneutralmateriality 3/10

14-01-2026

ImmunityBio, Inc. filed a Form 8-K on January 14, 2026 (AccNo: 0001326110-26-000004, Size: 296 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financials, or quantitative data are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with exhibits attached.

INTUITIVE SURGICAL INC8-Kneutralmateriality 5/10

14-01-2026

Intuitive Surgical Inc filed a Form 8-K on January 14, 2026 (AccNo: 0001035267-26-000003, Size: 348 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure event from the US market. No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary.

NexMetals Mining Corp.8-Kneutralmateriality 3/10

14-01-2026

NexMetals Mining Corp. filed a Form 8-K on January 14, 2026 (AccNo: 0001493152-26-002282, Size: 236 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer position, appointment/resignation status, reasons, or any quantitative data such as compensation or share counts are provided in the summary. Sector is not specified.

Get daily alerts with 3 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 6 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
Nasdaq 100 Stocks SEC Filings β€” January 13, 2026 | Gunpowder Blog